Patents by Inventor Haribabu Bodduluri

Haribabu Bodduluri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12377069
    Abstract: In some embodiments of the invention, inventive compounds (e.g., Formula (I), (IA), (II), and (III), and urolithin derivatives) are disclosed. Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inventive compound. Still other embodiments of the invention include compositions (e.g., pharmaceutical compositions) for treating, for example, certain diseases using the inventive compounds. Some embodiments include methods of using the inventive compound (e.g., in compositions or in pharmaceutical compositions) for administering and treating (e.g., diseases). Further embodiments include methods for making the inventive compounds. Additional embodiments of the invention are also discussed herein.
    Type: Grant
    Filed: October 26, 2023
    Date of Patent: August 5, 2025
    Assignees: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC., THE INSTITUTE FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE (INSTEM)
    Inventors: Venkatakrishna Rao Jala, Haribabu Bodduluri, Rajbir Singh, Praveen Kumar Vemula, Sandeep Chandrashekharappa, Ankita Arun Hiwale
  • Publication number: 20240173288
    Abstract: In some embodiments of the invention, inventive compounds (e.g., Formula (I), (IA), (II), and (III), and urolithin derivatives) are disclosed. Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inventive compound. Still other embodiments of the invention include compositions (e.g., pharmaceutical compositions) for treating, for example, certain diseases using the inventive compounds. Some embodiments include methods of using the inventive compound (e.g., in compositions or in pharmaceutical compositions) for administering and treating (e.g., diseases). Further embodiments include methods for making the inventive compounds. Additional embodiments of the invention are also discussed herein.
    Type: Application
    Filed: October 26, 2023
    Publication date: May 30, 2024
    Applicants: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC., THE INSTITUTE FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE (INSTEM)
    Inventors: Venkatakrishna Rao JALA, Haribabu BODDULURI, Rajbir SINGH, Praveen Kumar VEMULA, Sandeep CHANDRASHEKHARAPPA, Ankita Arun HIWALE
  • Publication number: 20210267932
    Abstract: In some embodiments of the invention, inventive compounds (e.g., Formula (I), (IA), (II), and (III), and urolithin derivatives) are disclosed. Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inventive compound. Still other embodiments of the invention include compositions (e.g., pharmaceutical compositions) for treating, for example, certain diseases using the inventive compounds. Some embodiments include methods of using the inventive compound (e.g., in compositions or in pharmaceutical compositions) for administering and treating (e.g., diseases). Further embodiments include methods for making the inventive compounds. Additional embodiments of the invention are also discussed herein.
    Type: Application
    Filed: May 14, 2019
    Publication date: September 2, 2021
    Applicants: University of Louisville Research Foundation, Inc., The Institute for Stem Cell Biology and Regenerative Medicine (InStem)
    Inventors: Venkatakrishna Rao JALA, Haribabu BODDULURI, Rajbir SINGH, Praveen Kumar VEMULA, Sandeep CHANDRASHEKHARAPPA, Ankita Arun HIWALE
  • Patent number: 9873878
    Abstract: A method for treating an inflammatory disease is provided. The method comprises administering an effective amount of a BLT1 inhibitor to a subject in need thereof. The BLT1 inhibitor is selected from the group consisting of a BLT1 receptor antagonist, a small molecule, a polypeptide, an siRNA, or a combination thereof.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: January 23, 2018
    Assignee: University of Louisville Research Foundation, Inc.
    Inventors: Haribabu Bodduluri, Shuchismita R. Satpathy, Venkatakrishna R. Jala
  • Publication number: 20160289688
    Abstract: A method for treating an inflammatory disease is provided. The method comprises administering an effective amount of a BLT1 inhibitor to a subject in need thereof. The BLT1 inhibitor is selected from the group consisting of a BLT1 receptor antagonist, a small molecule, a polypeptide, an siRNA, or a combination thereof.
    Type: Application
    Filed: March 30, 2016
    Publication date: October 6, 2016
    Inventors: Haribabu Bodduluri, Shuchismita R. Satpathy, Venkatakrishna R. Jala